HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.

3rd Edition of International Conference on Gastroenterology

September 27-29, 2027 London, UK

September 27 -29, 2027 | London, UK
Gastro 2027

Conjugated linolenic acid: From yesterday to tomorrow

Speaker at Gastroenterology Conferences - Pubali Dhar
University of Calcutta, India
Title : Conjugated linolenic acid: From yesterday to tomorrow

Abstract:

Dietary lipids have long been viewed primarily as dense energy sources or cardiovascular risk factors. Over the past three decades, however, nutritional lipidology has undergone a quiet revolution, recognizing conjugated fatty acids as potent physiological modulators. Among these, conjugated linolenic acid (CLnA)—specifically the 9 cis, 11 trans, 13 trans octadecatrienoic isomer (alpha-eleostearic acid) abundant in bitter gourd (Momordica charantia) seed oil—has emerged as a remarkable bioactive molecule. Tracing its scientific trajectory from basic nutritional biochemistry to targeted nanodelivery reveals how natural dietary fats can bridge the gap between everyday nutrition and therapeutic intervention.

Early foundational investigations established that dietary supplementation with CLnA-rich bitter gourd oil significantly attenuates non-enzymatic lipid peroxidation in hepatic tissues and erythrocyte membranes without adversely disrupting serum cholesterol homeostasis. Building on these baseline metabolic insights, subsequent research demonstrated CLnA's protective capacity under oxidative stress, showing that it shields plasma, low-density lipoproteins, and red blood cell membranes from oxidative damage in both diabetic and non-diabetic models, outperforming conventional antioxidants like alpha-tocopherol in curbing diabetes-induced lipid peroxidation.

As the field progressed, a critical challenge surfaced: poor aqueous solubility and limited gastrointestinal bioaccessibility restricted CLnA’s clinical translation. To overcome this bottleneck, research pivoted toward food-grade colloidal engineering. Encapsulating alpha-eleostearic acid in biocompatible nanoemulsions markedly improved gastrointestinal absorption and cellular uptake compared with conventional macroemulsions. In preclinical models, these nanoformulations not only delivered superior prophylactic protection against oxidative stress and metabolic dysfunction in diabetes, but also modulated systemic inflammatory cascades and hypersensitivity pathogenesis. Parallel explorations into lipid-gut interactions further underscored how structured functional lipids and bioactive matrices preserve intestinal mucosal integrity and foster beneficial gut microbial ecosystems.

The journey of conjugated linolenic acid exemplifies the maturation of functional food science—evolving from crude seed oil feeding trials in the late 1990s to precision nano-lipid therapeutics today. By pairing indigenous plant-derived bioactives with advanced gastrointestinal delivery platforms, CLnA offers a compelling, sustainable strategy for managing oxidative stress, metabolic syndrome, and gut-mediated inflammation.

Biography:

Dr Pubali Dhar is serving as a Professor at the Laboratory of Food Science & Technology, Food & Nutrition division, and associate faculty of Centre for research in Nanoscience and Nanotechnology, University of Calcutta. Her research team is primarily engaged in exploring different aspects of functional food and nano lipid technology. Having an h-index of 26, i10 index 50, more than 60 SCI journal publications, one patent with 2409 citations and post-graduate teaching experience over 20 years, she has demonstrated her research and teaching acumen quite conspicuously and consistently. She has supervised 15 Ph.D. thesis. She is presently the Vice President of Oil Technology Association of India, Eastern Zone and Convener of Nutrition Society of India Kolkata Chapter.

Watsapp